EMEA-001108-PIP02-15

Key facts

Active substance
Cadazolid
Therapeutic area
Infectious diseases
Decision number
P/0186/2016
PIP number
EMEA-001108-PIP02-15
Pharmaceutical form(s)
Granules for oral suspension
Condition(s) / indication(s)
Treatment of Clostridium difficile infection
Route(s) of administration
Oral use
Contact for public enquiries
Actelion Registration Ltd
Switzerland
Tel. +41 6156 56565
Fax +41 6156 56410
E-mail: medinfo@actelion.com
Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating